Korean J Blood Transfus.  2016 Dec;27(3):265-273. 10.17945/kjbt.2016.27.3.265.

Results of Proficiency Tests for HBsAg and Anti-HCV as the Blood Donor Screening Testing (2012~2015)

Affiliations
  • 1The Division of Human Blood Safety Surveillance, Korea Centers for Disease Control and Prevention, Cheongju, Korea. drlord@korea.kr
  • 2Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • 3Armed Forces Medical Research Institute, Daejeon, Korea.
  • 4Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • 5Department of Laboratory Medicine, Chungnam National University Hospital, Daejeon, Korea.
  • 6The Division of Laboratory Diagnosis Control for Infectious Diseases, Korea Centers for Disease Control and Prevention, Cheongju, Korea.
  • 7The Division of Korea National Health and Nutrition Examination Survey, Korea Centers for Disease Control and Prevention, Cheongju, Korea.

Abstract

BACKGROUND
Donor screening test is one of the most important processes for blood safety management. Korea Center for Disease Control and Prevention (KCDC) has been conducting an annual proficiency test program that includes the distribution of specially manufactured panels for hepatitis B surface antigen (HBsAg) and antibody to hepatitis C virus (anti-HCV) to blood centers. Here, KCDC reports the results of these proficiency tests for HBsAg and anti-HCV blood donor screening for all licensed blood centers in Korea between 2012 and 2015.
METHODS
Panels for the proficiency tests were manufactured and distributed to blood centers by Chung-Ang University Hospital, which has been participating in the Korea Blood Safety Commission. Well-proven reactive sera and healthy donor's sera acquired from the Human Serum Bank in Chung-Ang University were used to make the panels. To identify the S/CO ratio of the panel, three medical institutes triple-checked the results of each panel.
RESULTS
Most blood centers reported correct answers for the proficiency test with six panels. The average percentages (year) of correct answers were as follows: 98.7% (2012), 98.5% (2013), 99.1% (2014) and 99.6% (2015) for the HBsAg proficiency tests; and 97.7% (2012), 99.5% (2013), 99.1% (2014), and 99.8% (2015) for the anti-HCV proficiency tests.
CONCLUSION
To improve the blood center's ability for donor screening tests, KCDC will continue the proficiency test program by managing specialized panels for HBsAg and Anti-HCV tests. Furthermore, we will investigate the level of satisfaction to improve the quality of the program.

Keyword

HBsAg; Anti-HCV; Proficiency test; Blood center; Donor screening test

MeSH Terms

Academies and Institutes
Blood Donors*
Blood Safety
Centers for Disease Control and Prevention (U.S.)
Donor Selection
Hepacivirus
Hepatitis B Surface Antigens*
Humans
Korea
Mass Screening*
Hepatitis B Surface Antigens
Full Text Links
  • KJBT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr